The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Anyone know what are the actual disclosure rules for a fund selling a material stake ? Can they do it quietly, without their sales trans being shown immediately, and then an RNS within a day or so ? Doesn't seem right to me that the sales trans are delayed because this is market sensitive information and all parties are meant to be on an equal playing field. I'll phone the LSE tomorrow.
Companies going bust! Methinks I will. Definitely be buying tomorrow hopefully it might drop a bit more in the first half hour or so. :-).
Elliott exit or stake reduction imho.
Added a small amount more before the close.
Now worth 26bn with 10bn of debt, and Unilever offered 50bn , so 14bn difference now , this split did not maximise shareholder value , a sale would have deliver 14bn more value
Drop here and in GSK today looks very suspicious. C 4.5% drop in GSK and over 6% in HLN when markets are well up.....the Regulator should delve into these to establish who sold and whether legitimate or not.
Why down so much today, no specific news around ?
I'm back in & 2.85 and '87.
Good time to add ?
Wish i waited....... second visit now 2.86p paid ...probably another board member buying Gla
HLN ....missed buying at 2.86p.....bounced up to 3.10p... took a few now ... maiden debut..lets see what the short term holds. ....... GLA
Non-Execs buy half a million quids worth. Positive news I'd say.
After a bit more thought, my figures don't account for any dividends paid out. HLN was nil to date but there have been quite a few over the years for GSK.
Ill try putting in old GSK numbers v GSK demerged + HLN
Director buys ,so am I now. Add on the lows as best I can.
Had I not sold just prior to the split, I would be down about 8% on the GSK portion and down about 5% on the HLN portion. So neither doing great but, yes, HLN are doing slightly better.
Just noticed that my HLN shares are showing a bigger increase % wise than GSK. I assume using the split figures were equal on the day, I will have to check.
I might have to add some bits to my spreadsheet to highlight the benefits' or not of the split. It should be the same for everyone
Johnpwh, maybe you are right but the experts don't agree with you. A vast array of publications and research papers state that Brands survive best in recessions. In fact the brands that Haleon own are in the best sector for survival. See
https://brandfinance.com/insights/how-brands-can-overcome-crises
I draw everyone's attention to the table "Anticipated Loss in Brand Value by Sector in Response to Related Covid-19 Crises". This is no longer a Covid crisis but evidence is in plenty of sources. Here is a £2.69 book that can educate us all:
https://www.amazon.co.uk/Brand-Success-Worlds-Brands-Survive/dp/0749462876
If you are cheapskate you can always read the summary provided by Amazon.
johnpwh have you tried Wilkos? Some real bargains to be had..
I agree fatprofits, just on reflection HLN isn't my thing. I do think this current inflationary period is going to hurt premium products. Put it this way, I have never been and Aldi/ Lidl sort of chap but I now find myself sneaking in there more often and thinking 'actually this is pretty good for quite a few items'. Help me.....
That’s another two companies I will be adding to my portfolio at some stage . Trying to stick with proven strong companies from now on and less speculative shares.
John, these brands have existed for decades and in recessions
and better times. I get your general point but if you look
at the recent RKT or ULVR price action, the market appear to
be taking a more positive view of consumer goods stocks.
The way the sp is dropping I will be adding soon. Keep dropping.:-).
"I decided to ditch my Haleon shares a couple of days back at just under £3.20 and reinvest the proceeds in more GSK."
I'm still keeping an eye on both, although it's far more likely I'll get back into GSK than HLN.
I decided to ditch my Haleon shares a couple of days back at just under £3.20 and reinvest the proceeds in more GSK. The SP movement in the 2 has been favourable since. Logically, if that's how you can describe what passes as such with me, I would never have invested originally in a pure consumer products company marketing flashy and expensive generic items at a time when consumers are feeling the pinch and will be looking for cheaper alternatives.
Reasonably happy with the direction of HLN as I don't have funds to top up this week. Will get some meaty dividends at the end of today however and may buy on Monday. Probably not at the bottom though!
"Sir Dave will receive total fees of £700,000 per annum as Non-Executive Chair of the listed Consumer Healthcare company and will be required to invest an element of his net fees in company shares"
Looks like, at 316.7p, he didn't get the best of prices for his 200,000 worth of shares yesterday. Down well over 13,000 already.